Alto Neuroscience, Inc. (NYSE: ANRO) reported Q1 EPS of ($0.56), $0.01 better than the analyst estimate of ($0.57).

For earnings history and earnings-related data on Alto Neuroscience, Inc. (ANRO) click here.